Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « Chun-Ming Tsai »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Chun-Long Chen < Chun-Ming Tsai < Chun-Wei Tung  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000D37 (2016) Keunchil Park [Corée du Sud] ; Eng-Huat Tan [Singapour] ; Ken O'Byrne [Australie] ; Li Zhang [République populaire de Chine] ; Michael Boyer [Australie] ; Tony Mok [Hong Kong] ; Vera Hirsh [Canada] ; James Chih-Hsin Yang [Taïwan] ; Ki Hyeong Lee [Corée du Sud] ; Shun Lu [République populaire de Chine] ; Yuankai Shi [République populaire de Chine] ; Sang-We Kim [Corée du Sud] ; Janessa Laskin [Canada] ; Dong-Wan Kim [Corée du Sud] ; Catherine Dubos Arvis [France] ; Karl Kölbeck [Suède] ; Scott A. Laurie [Canada] ; Chun-Ming Tsai [Taïwan] ; Mehdi Shahidi [Royaume-Uni] ; Miyoung Kim [Allemagne] ; Dan Massey [Royaume-Uni] ; Victoria Zazulina [Royaume-Uni] ; Luis Paz-AresAfatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.
001218 (2015) James Chih-Hsin Yang [Taïwan] ; Yi-Long Wu [République populaire de Chine] ; Martin Schuler [Allemagne] ; Martin Sebastian [Allemagne] ; Sanjay Popat [Royaume-Uni] ; Nobuyuki Yamamoto [Japon] ; Caicun Zhou [République populaire de Chine] ; Cheng-Ping Hu [République populaire de Chine] ; Kenneth O'Byrne [Australie] ; Jifeng Feng [République populaire de Chine] ; Shun Lu [République populaire de Chine] ; Yunchao Huang [République populaire de Chine] ; Sarayut L. Geater [Thaïlande] ; Kye Young Lee [Corée du Sud] ; Chun-Ming Tsai [Taïwan] ; Vera Gorbunova [Russie] ; Vera Hirsh [Canada] ; Jaafar Bennouna [France] ; Sergey Orlov [Russie] ; Tony Mok [République populaire de Chine] ; Michael Boyer [Australie] ; Wu-Chou Su [Taïwan] ; Ki Hyeong Lee [Corée du Sud] ; Terufumi Kato [Japon] ; Dan Massey [Royaume-Uni] ; Mehdi Shahidi [Royaume-Uni] ; Victoria Zazulina [Royaume-Uni] ; Lecia V. Sequist [États-Unis]Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.
001B41 (2013) Lecia V. Sequist [États-Unis] ; James Chih-Hsin Yang [Taïwan] ; Nobuyuki Yamamoto [Japon] ; Kenneth O'Byrne [Irlande (pays)] ; Vera Hirsh [Canada] ; Tony Mok [République populaire de Chine] ; Sarayut Lucien Geater [Thaïlande] ; Sergey Orlov [Russie] ; Chun-Ming Tsai [Taïwan] ; Michael Boyer [Australie] ; Wu-Chou Su [Taïwan] ; Jaafar Bennouna [France] ; Terufumi Kato [Japon] ; Vera Gorbunova [Russie] ; KI HYEONG LEE [Corée du Sud] ; Riyaz Shah [Canada] ; Dan Massey [Royaume-Uni] ; Victoria Zazulina [Royaume-Uni] ; Mehdi Shahidi [Royaume-Uni] ; Martin Schuler [Allemagne]Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Adult
2Aged
2Aged, 80 and over
2Female
2Humans
2Male
2Middle Aged
2Mutation
2Pemetrexed
2Receptor, Epidermal Growth Factor (genetics)
1Adenocarcinoma (drug therapy)
1Adenocarcinoma (genetics)
1Adenocarcinoma (mortality)
1Adenocarcinoma (pathology)
1Advanced stage
1Afatinib
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Antineoplastic agent
1Bronchopulmonary adenocarcinoma
1Cancerology
1Carcinoma, Non-Small-Cell Lung (drug therapy)
1Carcinoma, Non-Small-Cell Lung (genetics)
1Carcinoma, Non-Small-Cell Lung (pathology)
1Cisplatin
1Cisplatin (administration & dosage)
1Deoxycytidine (administration & dosage)
1Deoxycytidine (analogs & derivatives)
1Disease-Free Survival
1Drug-Related Side Effects and Adverse Reactions (classification)
1Drug-Related Side Effects and Adverse Reactions (genetics)
1Drug-Related Side Effects and Adverse Reactions (physiopathology)
1Epidermal growth factor receptor
1Follow-Up Studies
1Genetics
1Glutamates (administration & dosage)
1Guanine (administration & dosage)
1Guanine (analogs & derivatives)
1Human
1Kaplan-Meier Estimate
1Lung Neoplasms (drug therapy)
1Lung Neoplasms (genetics)
1Lung Neoplasms (mortality)
1Lung Neoplasms (pathology)
1Lung cancer
1Metastasis
1Mutation (genetics)
1Neoplasm Staging
1Phase III trial
1Prognosis
1Protein Kinase Inhibitors (administration & dosage)
1Protein Kinase Inhibitors (adverse effects)
1Quinazolines (administration & dosage)
1Quinazolines (adverse effects)
1Quinazolines (therapeutic use)
1Receptor, Epidermal Growth Factor (antagonists & inhibitors)
1Survival Rate
1Treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Chun-Ming Tsai" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Chun-Ming Tsai" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Chun-Ming Tsai
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024